Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BOTOX in the Treatment of Crow's Feet Lines in Japan

Next Previous
Trial Profile

BOTOX in the Treatment of Crow's Feet Lines in Japan

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 17 Apr 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Facial wrinkles
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergan

Most Recent Events

  • 23 May 2016 According to Allergan media release, the Japanese Ministry of Health, Labour and Welfare has approved an additional use for BOTOX Vista (Allergan's botulinum toxin type A product) as a treatment for crow's feet lines (CFL).
  • 23 May 2016 Results published in Allergan media release.
  • 01 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top